We are live on ! Find out more
CB

Christopher Bloomstran Semper Augustus Investments Group

AUM $885M
1-Year Est. Return 30.72%
 

Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.

This Fund
S&P 500
This Quarter Est. Return
-2.69%
1 Year Est. Return
+30.72%
3 Year Est. Return
+95.38%
5 Year Est. Return
+117.62%
10 Year Est. Return
+411.84%
AUM
$154M
AUM Growth
-$2.73M
Cap. Flow
+$1.85M
Cap. Flow %
1.2%
Top 10 Hldgs %
74.38%
Holding
32
New
2
Increased
4
Reduced
6
Closed
1

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$398K
2
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$34K
3
JNJ icon
Johnson & Johnson
JNJ
+$12.7K
4
EQNR icon
Equinor
EQNR
+$7.13K
5
NEM icon
Newmont
NEM
+$7.01K

Sector Composition

Rank Sector Weight
1 Financials 51.97%
2 Energy 15.77%
3 Materials 7.85%
4 Healthcare 7.62%
5 Technology 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.06T
$28.4M 18.47%
196,835
+100
+0.1% +$14.7K
XOM icon
2
ExxonMobil
XOM
$679B
$21.7M 14.11%
255,232
BRK.A icon
3
Berkshire Hathaway Class A
BRK.A
$1.06T
$18.7M 12.16%
86
MCY icon
4
Mercury Insurance
MCY
$5.85B
$11.5M 7.45%
198,443
GG
5
DELISTED
Goldcorp Inc
GG
$9.01M 5.86%
497,092
+832
+0.2% +$17.7K
JEF icon
6
Jefferies Financial Group
JEF
$12.1B
$6.99M 4.55%
350,303
WAFD icon
7
WaFd
WAFD
$2.69B
$5.3M 3.45%
243,173
MRK icon
8
Merck
MRK
$376B
$4.54M 2.95%
82,849
-7,021
-8% -$398K
SNY icon
9
Sanofi
SNY
$110B
$4.36M 2.83%
88,140
INTC icon
10
Intel
INTC
$476B
$3.91M 2.55%
125,156
GE icon
11
GE Aerospace
GE
$361B
$3.73M 2.43%
31,368
MSFT icon
12
Microsoft
MSFT
$3.59T
$3.5M 2.27%
86,014
+539
+0.6% +$23.5K
AVX
13
DELISTED
AVX Corporation
AVX
$3.12M 2.03%
218,397
COST icon
14
Costco
COST
$420B
$3.09M 2.01%
20,402
VR
15
DELISTED
Validus Hold Ltd
VR
$2.42M 1.57%
57,431
RBA icon
16
RB Global
RBA
$16.1B
$2.37M 1.54%
95,000
EQNR icon
17
Equinor
EQNR
$102B
$2.27M 1.47%
128,955
-400
-0.3% -$7.13K
TRV icon
18
Travelers Companies
TRV
$75.8B
$2.16M 1.41%
20,000
PEP icon
19
PepsiCo
PEP
$196B
$2.16M 1.4%
22,593
-50
-0.2% -$4.84K
JNJ icon
20
Johnson & Johnson
JNJ
$651B
$2.04M 1.32%
20,238
-125
-0.6% -$12.7K
KO icon
21
Coca-Cola
KO
$392B
$2.03M 1.32%
50,000
AXP icon
22
American Express
AXP
$227B
$1.89M 1.23%
+24,143
New +$2.01M
NEM icon
23
Newmont
NEM
$139B
$1.83M 1.19%
84,093
-300
-0.4% -$7.01K
CBI
24
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.65M 1.07%
33,395
+90
+0.3% +$3.79K
CNA icon
25
CNA Financial
CNA
$13.3B
$1.58M 1.03%
38,155

Similar funds

Christopher Bloomstran's Q1 2015 Portfolio in Review

As of Q1 2015, Christopher Bloomstran held 32 positions worth $154M, down 1.7% from $157M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Christopher Bloomstran's Q1 2015 filing shows 2 new, 4 increased, 6 reduced and 1 closed positions. Its largest new stake was American Express: 24,143 shares worth $1.89M. The largest sale was Merck, an estimated $398K.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 51% a quarter earlier, followed by Energy and Materials.

  • Christopher Bloomstran's largest Q1 2015 buy was American Express: 24,143 shares worth $1.89M.
  • Christopher Bloomstran added most to Microsoft in Q1 2015, an estimated $23.5K increase.
  • Christopher Bloomstran's biggest Q1 2015 reduction was Merck, cutting an estimated $398K.
  • Christopher Bloomstran fully exited Ampio Pharmaceuticals Inc. in Q1 2015, selling an estimated $34K.
  • Christopher Bloomstran's ten largest holdings make up 74% of its $154M portfolio in Q1 2015.
  • Christopher Bloomstran opened 2 new positions and closed 1 in Q1 2015.
  • Christopher Bloomstran's portfolio value fell 1.7% quarter-over-quarter to $154M.

Based on Semper Augustus Investments Group's 13F filing for Q1 2015, filed 14 May 2015.